Intermittent clonidine regimen abolishes tolerance to its antihypertensive effect: A spectral study

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 3, 2007, Pages 174-181

  El Mas, Mahmoud M ^a   Abdel Rahman, Abdel A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Blood pressure; Clonidine; Spectral analysis; Spontaneously hypertensive rats; Urine analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLONIDINE; ELECTROLYTE; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DIET; DRUG TOLERANCE; FOURIER TRANSFORMATION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART RATE; HYPERTENSION; HYPOTENSION; MALE; NONHUMAN; NORADRENALIN URINE LEVEL; PLASMA OSMOLALITY; PRIORITY JOURNAL; RAT; SPECTROSCOPY; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; TELEMETRY; URINE OSMOLALITY; URINE VOLUME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; ELECTROLYTES; FOURIER ANALYSIS; HEART RATE; HYPERTENSION; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; OSMOLAR CONCENTRATION; RATS; RATS, INBRED SHR; TELEMETRY;

EID: 34147223383     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3180318afb     Document Type: Article

References (44)

1. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther. 2002;93:1-35.
2. Bousquet P, Greney H, Bruban V, et al. I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going? Ann N Y Acad Sci. 2003;1009:228-233.
3. Parkin ML, Godwin SJ, Head GA. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits. J Hypertens. 2003;21:167-178.
4. Davidov M, Kakaviatos N, Finnerty FA Jr. The antihypertensive effects of an imidazoline compound. Clin Pharmacol Ther. 1967;8:810-816.
5. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914-921.
6. El-Mas MM, Abdel-Rahman AA. Chronic ethanol-clonidine hemodynamic interaction in telemetered spontaneously hypertensive rats. Vascul Pharmacol. 2004;41:107-113.
7. Chaouche-Teyara K, Lacolley P, Challande P, et al. Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1997;30:241-244.
8. Eerdmans PH, Struyker Boudier HA, De Mey JG. Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats. J Hypertens. 1991;9(Suppl 6):S348-S349.
9. Monassier L, Greney H, Thomas L, et al. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration. J Cardiovasc Pharmacol. 2004;43:394-401.
10. Parkin ML, Godwin SJ, Head GA. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits. J Hypertens. 2003;21:167-178.
11. Chan CKS, Sannajust F, Head GA. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J Pharmacol Exp Ther. 1996;276:411-420.
12. 1-imidazoline sites. J Pharmacol Exp Ther. 1993;264:172-182.
13. Naruse T, Ishii R, Tagawa T. Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats. Jpn J Pharmacol. 1995;67:407-410.
14. Hess RW, Hardman SL, Shirachi DY, et al. Comparison between osmotic mini-pumps and controlled release pellets in chronic clonidine administration in the spontaneously hypertensive rat. Proc West Pharmacol Soc. 1985;28:97-101.
15. Ferrari AU, Daffonchio A, Albergati F, et al. Intra-arterial pressure alterations during tail-cuff blood pressure measurements in normotensive and hypertensive rats. J Hypertens. 1990;8:909-911.
16. Hoobler SW, Sagastume E. Clonidine hydrochloride in the treatment of hypertension. Am J Cardiol. 1971;28:67-73.
17. 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery. Br J Pharmacol. 1989;96:539-546.
18. Hamilton CA, Yakubu MA, Howie CA, et al. Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites? Clin Exper Hypertens. 1992;14(Suppl 5):815-835.
19. Reid K, Hayashi Y, Maguire P, et al. The pertussis toxin-sensitive G protein uncouples from the alpha sub 2 adrenoceptor in the locus ceruleus of alpha sub 2-tolerant rats [abstract]. Anesthesiology. 1993;79:728.
20. Portenoy RK, Savage SR. Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy - tolerance and addiction. J Pain Symptom Manage. 1997;14(Suppl 3):S27-S35.
21. El-Mas MM, Abdel-Rahman AA. Radiotelemetric evaluation of the hemodynamic effects of long-term ethanol in spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther. 2000;292:944-951.
22. El-Mas MM, Abdel-Rahman AA. An association between the estrogen-dependent hypotensive effect of ethanol and an elevated brainstem c-jun mRNA in female rats. Brain Res. 2001;912:79-88.
23. El-Mas MM, Abdel-Rahman AA. Effects of chronic ethanol feeding on clonidine-evoked reductions in blood pressure, heart rate, and their variability: time-domain analyses. J Pharmacol Exp Ther. 2003;306:271-278.
24. van den Buuse M. Acute effects of antipsychotic drugs on cardiovascular responses to stress. Eur J Pharmacol. 2003;464:55-62.
25. Stein PK, Bosner MS, Kleiger RE, et al. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J. 1994;127:1376-1381.
26. Japundzic-Zigon N. Physiological mechanisms in regulation of blood pressure fast frequency variations. Clin Exp Hypertens. 1998;20:359-388.
27. Young JB, Weiss J, Boufath N. Effects of rearing temperature on sympathoadrenal activity in young adult rats. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1198-R1209.
28. Oishi S, Sasaki M, Ohno M, et al. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24 hour and random 1 hour urine determinations. J Clin Endocrinol Metab. 1988;67:614-618.
29. I) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. J Hypertens. 1997;15:117-125.
30. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000;36:894-900.
31. Parati G, Ulian L, Santucciu C, et al. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens. 1995;13(Suppl 4):S27-S34.
32. Strauer BE. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease. J Cardiovasc Pharmacol. 1988;12(Suppl 4):S45-S54.
33. Esler M, Kaye D. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst. 1998;72:210-219.
34. Csongrady A, Kobinger W. Investigations into the positive inotropic effect of clonidine in isolated hearts. Naunyn Schmiedebergs Arch Pharmacol. 1974;282:123-128.
35. Medgett IC, McCulloch MW. Receptor sites of action of clonidine: effects of clonidine and three structural isomers on prejunctional and postjunctional alpha-adrenoceptors and histamine H2-receptors in guinea-pig isolated cardiovascular tissues. J Pharm Pharmacol. 1980;32:137-138.
36. Campese VM, Romoff M, Telfer N, et al. Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension. Kidney Int. 1980;18:351-357.
37. Thananopavarn C, Golub MS, Eggena P, et al. Clonidine, a centrally acting sympathetic inhibitor, as monotherapy for mild to moderate hypertension. Am J Cardiol. 1982;49:153-158.
38. Goldberg M, Gehr M. Effects of alpha-2 agonists on renal function in hypertensive humans. J Cardiovasc Pharmacol. 1985;7(Suppl 8):S34-S37.
39. El-Mas MM, Abdel-Rahman AA. Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats. Life Sci. 2005;76:901-915.
40. Kuo TB, Lai CJ, Shaw FZ, et al. Sleep-related sympathovagal imbalance in SHR. Am J Physiol Heart Circ Physiol. 2004;286:H1170-H1176.
41. Kuo TB, Shaw FZ, Lai CJ, et al. Changes in sleep patterns in spontaneously hypertensive rats. Sleep. 2004;27:406-412.
42. Eilam R, Malach R, Bergmann F, et al. Hypertension induced by hypothalamic transplantation from genetically hypertensive to normotensive rats. J Neurosci. 1991;11:401-411.
43. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14:280S-290S.
44. Portaluppi F, Vergnani L, Manfredini R, et al. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719-726.